Jolana Cermanova, Zuzana Kadova, Eva Dolezelova, Marie Zagorova, Vaclav Safka, Milos Hroch, Tomas Laho, Magdalena Holeckova, Jaroslav Mokry, Petra Kovarikova, Jan Bures, Martin Sterba, Stanislav Micuda
Index: Shock 42(4) , 372-9, (2014)
Full Text: HTML
The purpose of the present study was to compare the activity of two different clinically available iron chelators on the development of acute liver injury after administration of the bacterial endotoxin (lipopolysaccharide [LPS]) in rats. Lipopolysaccharide was administered either alone or after pretreatment with dexrazoxane (DEX) or deferoxamine (DFO). Control groups received only saline or its combination with either chelator. After 8 h, untreated LPS rats developed liver injury, with signs of inflammation and oxidative stress. Lipopolysaccharide reduced plasma iron concentrations in association with increased production of hepcidin and the reduced liver expression of ferroportin. Administration of chelating agents to LPS animals showed distinct effects. Although both drugs were able to reduce liver iron content, together with corresponding changes in hepcidin and ferroportin expressions, only DFO showed a protective effect against liver injury despite relatively small liver concentrations. In sharp contrast, DEX failed to improve any hallmark of liver injury and even worsened the GSH/GSSG ratio, the indicator of oxidative stress in the tissue. High-performance liquid chromatography-mass spectrometry analysis showed marked liver accumulation of iron-chelating metabolite of DEX (ADR-925), whereas the parent compound was undetectable. Further downregulation of transporters involved in bile formation was observed after DFO in the LPS group as well as in healthy animals. Neither chelator imposed significant liver injury in healthy animals. In conclusion, we demonstrated marked differences in the modulation of endotoxemic liver impairment between two iron chelators, implicating that particular qualities of chelating agents may be of crucial importance.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Benzamidine
CAS:618-39-3 |
C7H8N2 | |
![]() |
Dexrazoxane
CAS:24584-09-6 |
C11H16N4O4 |
|
Assembly and structure of Lys33-linked polyubiquitin reveals...
2015-04-15 [Biochem. J. 467(2) , 345-52, (2015)] |
|
The Drosophila MAPK p38c regulates oxidative stress and lipi...
2014-09-01 [PLoS Genet. 10(9) , e1004659, (2014)] |
|
LATS1 and LATS2 phosphorylate CDC26 to modulate assembly of ...
2015-01-01 [PLoS ONE 10(2) , e0118662, (2015)] |
|
Stretch-stimulated glucose transport in skeletal muscle is r...
2015-02-01 [J. Physiol. 593(3) , 645-56, (2015)] |
|
Dimethyl sulphoxide and Ca2+ stimulate assembly of Vibrio ch...
2014-10-01 [Biochimie 105 , 64-75, (2014)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved

